Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Mogensen

Showing results (251-260 of 269) with videos related to

Pageof 27
Sort By:
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|June 14, 2003
Dual blockade with candesartan cilexetil and lisinopril in hypertensive patients with diabetes mellitus: rationale and designNiels H Andersen, Søren T Knudsen, Per L Poulsen, et al.
Acta Medica Scandinavica|January 1, 1987
Clinical outcome of using insulin at 40 IU/ml and 100 IU/ml in pump treatment. Results of a controlled multi-center trialJ S Christiansen, G E Sonnenberg, A Kverneland, et al.
Diabete & Metabolisme|September 1, 1994
Effects of captopril on ambulatory blood pressure, renal and cardiac function in microalbuminuric type 1 diabetic patientsK W Hansen, F Klein, P D Christensen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 20, 2005
Left ventricular dysfunction in hypertensive patients with Type 2 diabetes mellitusN H Andersen, S H Poulsen, P L Poulsen, et al.
The Journal of Diabetic Complications|October 1, 1990
Renal and glycemic determinants of glomerular hyperfiltration in normoalbuminuric diabeticsC E Mogensen, C K Christensen, M M Pedersen, et al.
The EMBO Journal|October 16, 1995
Mutant U5A cells are complemented by an interferon-alpha beta receptor subunit generated by alternative processing of a new member of a cytokine receptor gene clusterG Lutfalla, S J Holland, E Cinato, et al.
Diabetes Care|March 1, 2006
Does albuminuria predict cardiovascular outcomes on treatment with losartan versus atenolol in patients with diabetes, hypertension, and left ventricular hypertrophy? The LIFE studyHans Ibsen, Michael H Olsen, Kristian Wachtell, et al.
Clinical Science (London, England : 1979)|March 4, 2006
Effects of blood pressure lowering and metabolic control on systolic left ventricular function in Type II diabetes mellitusNiels H Andersen, Steen H Poulsen, Per L Poulsen, et al.
Kidney International|May 3, 2014
Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global OutcomesMark E Molitch, Amanda I Adler, Allan Flyvbjerg, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 29, 2013
Efficacy and safety of sitagliptin in patients with type 2 diabetes and ESRD receiving dialysis: a 54-week randomized trialJuan C Arjona Ferreira, Dalila Corry, Carl E Mogensen, et al.
Pageof 27

Showing results (251-260 of 269) with videos related to

Sort By:
Pageof 27
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|June 14, 2003
Dual blockade with candesartan cilexetil and lisinopril in hypertensive patients with diabetes mellitus: rationale and designNiels H Andersen, Søren T Knudsen, Per L Poulsen, et al.
Acta Medica Scandinavica|January 1, 1987
Clinical outcome of using insulin at 40 IU/ml and 100 IU/ml in pump treatment. Results of a controlled multi-center trialJ S Christiansen, G E Sonnenberg, A Kverneland, et al.
Diabete & Metabolisme|September 1, 1994
Effects of captopril on ambulatory blood pressure, renal and cardiac function in microalbuminuric type 1 diabetic patientsK W Hansen, F Klein, P D Christensen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 20, 2005
Left ventricular dysfunction in hypertensive patients with Type 2 diabetes mellitusN H Andersen, S H Poulsen, P L Poulsen, et al.
The Journal of Diabetic Complications|October 1, 1990
Renal and glycemic determinants of glomerular hyperfiltration in normoalbuminuric diabeticsC E Mogensen, C K Christensen, M M Pedersen, et al.
The EMBO Journal|October 16, 1995
Mutant U5A cells are complemented by an interferon-alpha beta receptor subunit generated by alternative processing of a new member of a cytokine receptor gene clusterG Lutfalla, S J Holland, E Cinato, et al.
Diabetes Care|March 1, 2006
Does albuminuria predict cardiovascular outcomes on treatment with losartan versus atenolol in patients with diabetes, hypertension, and left ventricular hypertrophy? The LIFE studyHans Ibsen, Michael H Olsen, Kristian Wachtell, et al.
Clinical Science (London, England : 1979)|March 4, 2006
Effects of blood pressure lowering and metabolic control on systolic left ventricular function in Type II diabetes mellitusNiels H Andersen, Steen H Poulsen, Per L Poulsen, et al.
Kidney International|May 3, 2014
Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global OutcomesMark E Molitch, Amanda I Adler, Allan Flyvbjerg, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 29, 2013
Efficacy and safety of sitagliptin in patients with type 2 diabetes and ESRD receiving dialysis: a 54-week randomized trialJuan C Arjona Ferreira, Dalila Corry, Carl E Mogensen, et al.
Pageof 27